December 31, 2022
8 min watch
Save
VIDEO: Specialist discusses treatment options for central serous retinopathy
NEW YORK — In a presentation at OSN New York Retina, Avni P. Finn, MD, MBA, discusses when to treat patients for central serous retinopathy as well as the most effective treatments.
Finn uses topline data to evaluate the efficacy of different CSCR treatment options, including mineralocorticoid antagonists, laser photocoagulation, photodynamic therapy and subthreshold micropulse laser photocoagulation.
Published by:
Sources/Disclosures
Collapse
Source:
Finn AP. Chronic CSCR: What have we learned from longitudinal studies. Presented at: OSN New York and OSN New York Retina; Nov. 11-Nov. 13, 2022; New York.
Disclosures:
Finn reports consulting for Genentech and being on the advisory board for Alimera, Allergan and EyePoint.
Read more about